Oncolytics Biotech Inc. (ONCY)
NASDAQ: ONCY
· Real-Time Price · USD
1.38
-0.04 (-2.82%)
At close: Oct 03, 2025, 2:28 PM
-2.82% (1D)
| Bid | 1.37 |
| Market Cap | 137.75M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -30.41M |
| EPS (ttm) | -0.29 |
| PE Ratio (ttm) | -4.74 |
| Forward PE | -3.94 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 1.38 |
| Volume | 722,330 |
| Avg. Volume (20D) | 1,156,282 |
| Open | 1.42 |
| Previous Close | 1.42 |
| Day's Range | 1.36 - 1.42 |
| 52-Week Range | 0.33 - 1.53 |
| Beta | 1.24 |
| Ex-Dividend Date | n/a |
About ONCY
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ONCY
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ONCY stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 weeks ago
+20.75%
Oncolytics Biotech shares are trading higher after...
Unlock content with
Pro Subscription
3 months ago
+34.1%
Oncolytics Biotech shares are trading higher after the company announced it appointed Jared Kelly as CEO.
